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Abstract: Volume-stable collagen matrices (VSCM) are conductive for the connective tissue upon soft
tissue augmentation. Considering that collagen has osteoconductive properties, we have investigated
the possibility that the VSCM also consolidates with the newly formed bone. To this end, we covered
nine rat calvaria circular defects with a VSCM. After four weeks, histology, histomorphometry,
quantitative backscattered electron imaging, and microcomputed tomography were performed. We
report that the overall pattern of mineralization inside the VSCM was heterogeneous. Histology
revealed, apart from the characteristic woven bone formation, areas of round-shaped hypertrophic
chondrocyte-like cells surrounded by a mineralized extracellular matrix. Quantitative backscattered
electron imaging confirmed the heterogenous mineralization occurring within the VSCM. Histomor-
phometry found new bone to be 0.7 mm2 (0.01 min; 2.4 max), similar to the chondrogenic mineralized
extracellular matrix with 0.7 mm2 (0.0 min; 4.2 max). Microcomputed tomography showed the
overall mineralized tissue in the defect to be 1.6 mm3 (min 0.0; max 13.3). These findings suggest that
in a rat cranial defect, VSCM has a limited and heterogeneous capacity to support intramembranous
bone formation but may allow the formation of bone via the endochondral route.
Keywords: bone regeneration; volume-stable collagen matrix; collagen matrix; histology; qBEI
1. Introduction
Regenerative dentistry is an umbrella term for all procedures aiming to regain the
form and function of oral tissues that are lost, mainly due to periodontal and periapical
inflammatory osteolysis and the atrophy of the alveolar bone that occurs upon tooth
extraction [1]. Today, dental implants can replace lost teeth with the remaining challenge to
regenerate the lost bone, a process termed bone augmentation. Autologous bone, allografts,
or bone substitutes and combinations thereof guide the newly formed bone to mechanically
support the dental implants [2]. However, it also requires sufficient soft tissue to seal
the augmented site and the dental implant towards the oral cavity [3,4]. The soft tissue
dimension including its thickness can be a limitation to achieve a stable and esthetic
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outcome [5,6]. To overcome this limitation, a palate-derived connective tissue graft is used
to regenerate the lost gingiva tissue, a process termed soft tissue augmentation [5,6]. To
overcome the harvesting of the autografts, soft tissue substitutes were introduced to the
field [7,8].
Collagen matrices have gained significant attention in the field of regenerative den-
tistry as soft tissue substitutes for connective tissue grafts [9]. This is based on the cumu-
lative evidence that collagen matrices increase the soft tissue thickness and improve the
contour around implants and teeth before prosthetic reconstructions [10–12]. Collagen
matrices combine the clinical properties of connective tissue grafts, i.e., providing volume
stability based on compression-resistant properties, with the ability to allow consolida-
tion with the soft tissue at the augmentation site. Thus, a volume-stable collagen matrix
(VSCM) enables the ingrowth of the adjacent soft tissues into the sponge-like porous struc-
ture [13,14]. Furthermore, collagen is the main extracellular matrix to support hard tissue
regeneration. Therefore, it seems possible that the beneficial properties of VSCM are not
limited to soft tissue augmentation but may also encompass osteoconductive properties.
Recent studies showed the capability of VSCM to consolidate with soft tissue in
submucosal pouches of the canine maxilla. After around one month, a fibrous extracellular
matrix filled the pores, and with time, the collagen matrix became fully integrated into
soft tissue [13,14]. These studies support the claim that VSCM is conductive for soft tissue,
comparable to what we consider as osteoconductive when grafts provide a surface for the
newly formed bone during augmentation. Usually, there is a clear distinction between
the biomaterials and grafts used for soft and hard tissue augmentation. However, this
paradigm requires to be questioned, in particular, if it cannot be ruled out that a VSCM
holds osteoconductive properties.
First indications of possible osteoconductive behavior of VSCM stem from canine
models showing the partial integration of VSCM into new bone [15,16]. Moreover, VSCM is
cross-linked to increase the stiffness and stiffness is a parameter that was identified to affect
chondrogenesis of gelatin scaffolds [17,18]. With respect to the defect site, calvaria has
mesenchymal progenitors with an osteochondrogenic potential. Considering that collagen
fibrils support the crystallization of hydroxyapatite during bone formation [19] it might
be hypothesized that collagen-derived biomaterials in general, possess osteoconductive
properties. Support for this hypothesis comes from observations that native collagen-rich
membranes from the porcine peritoneum allow the accumulation of new bone [20,21].
These data support previous findings that new bone grows into the collagen membrane
in a rat calvarial defect model [22,23]. Even though previous studies were not designed
to study the osteoconductive properties of VSCM, they provide first insights towards this
capacity [15,16]. The present study aimed at explicitly investigating the osteoconductivity
of the porcine, porous, and cross-linked VSCM originally proposed for soft-tissue in a rat
calvarial defect model.
2. Material and Methods
2.1. Study Design
Nine 7-month-old female Sprague Dawley rats from the Division for Biomedical Re-
search (Himberg, Austria) were used. The animals were treated according to the guidelines
for animal care; they were kept in groups of three animals each in Macrolon cages type
IV with a day/night rhythm 1:1. Water and regular diet (ssniff Spezialdiäten GmbH,
Soest, Germany) was provided ad libitum. The Medical University of Vienna ethical re-
view board for animal research approved the study protocol (GZ BMWFW-66.009/0217-
WF/V/3b/114/2012.20). The study was performed in 2019 at the Department of Oral
Biology of the Medical University of Vienna in accordance with the ARRIVE guidelines [24].
The VSCM data are part of a larger study to evaluate the osteoconductive properties of
collagen-based biomaterials but with a different hypothesis. It is thus legitimate to consider
our data observed with a collagen membrane (Bio-Gide, Geistlich, Wolhusen, Switzerland)
as a positive control considering the osteogenic properties of the rat calvaria defect [25,26].
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2.2. Surgical Procedure
Two experienced periodontists performed the surgeries, and the operations were
performed under general anesthesia to minimize the stress with ketamine 100 mg/kg
(Pharmacia & Upjohn, Erlangen, Germany) and xylazine hydrochloride 5 mg/kg (Bayer,
Leverkusen, Germany) by intramuscular injection. An incision was made in the center
of the calvaria, and the periosteum was elevated to expose the cranial bony surface. One
standardized circular defect was surgically induced on the rat calvaria unilaterally apart
from the midsagittal suture, using a trephine drill with an external diameter of 5 mm
(Dentium, Suwon, Korea). Prefabricated VSCMs of porcine origin (20 × 40 × 6 mm;
Fibro-Gide, Geistlich, Wolhusen, Switzerland) were trimmed to cover the defects with
sheets of size 10 × 10 × 3 mm. According to the manufacturer, the VSCM underwent
chemical cross-linking. Wounds were closed with two layers of sutures (periosteum and
skin) using resorbable silk (Vicryl 5-0; Ethicon, Norderstedt, Germany). For postoperative
pain relief, butorphanol, 1.25 mg/kg (Richter Pharma AG, Wels, Austria) and meloxicam,
0.15 mg/kg (Boehringer Ingelheim Vetmedica GmbH, Ingelheim, Germany) were adminis-
tered subcutaneously. The animals were postoperatively observed by the veterinarians of
the Department of Biomedical Research of the Medical University of Vienna and by the
surgeons who recorded possible behavioral problems, obvious pain, swelling, redness, or
restricted mobility. One animal died during the healing period, the remaining nine animals
were euthanized four weeks after surgery by an intracardial overdose of thiopental (Sandoz
GmbH, Vienna, Austria).
2.3. Histological and Histomorphometric Analysis
The samples were dehydrated in an ascending alcohol series. Subsequently, they were
embedded in light-curing resin (Technovit 7200 VLC + BPO; Kulzer & Co., Wehrheim,
Germany). Blocks were further processed using EXAKT cutting and grinding equipment
(Exakt Apparatebau, Norderstedt, Germany). Thin-ground sections from all samples
were prepared in a plane parallel to the sagittal suture and through the center of the
defect and stained with Levai–Laczko dye, composed of azure II and methylene blue,
counterstain with safranin. The slides were scanned using an Olympus BX61VS digital
virtual microscopy system (DotSlide 2.4; Olympus, Japan, Tokyo) with a 20× objective
resulting in a resolution of 0.32 µm per pixel and then evaluated. For the histomorphometric
analysis, the ROI contained the central defect area between the edges of the parietal
bone and the ectocranial sides and above the defect area. The newly formed bone, the
bone incorporating VSCM, the mineralized extracellular matrix resembling hypertrophic
cartilage, the residual VSCM, and the soft tissue were measured. The different tissues were
segmented manually on the computer screen at a high resolution and then exported into
Fiji to obtain the correspondent histograms based on color-coded thresholding.
2.4. Quantitative Backscattered Electron Imaging (qBEI)
One specimen that showed a particular strong bone formation was used for qBEI
analysis. The details of the method can be found elsewhere [27,28] and are only shortly
recapitulated here. To achieve a conducting surface, the sample was carbon-coated (Agar
automatic SEM carbon coater, Agar Scientific Ltd., Stansted, Essex, UK) and subsequently
scanned with a field emission scanning electron microscope SUPRA40 (Zeiss, Oberkochen,
Germany). Prior to measurement, the device was calibrated with aluminum and carbon
standards allowing for the quantitative measurement of the local calcium content. Bit
grey level images with pixel resolution 0.882 µm were acquired. The obtained grey values
were then converted in calcium concentration in weight percent (wt.% Ca) and the bone
mineralization density distribution (BMDD) was evaluated. The BMDD is the frequency
distribution of local calcium content normalized to 100 % bone area [27]. The BMDD curve
is characterized by the following parameters: CaPeak, the most frequently measured calcium
concentration; CaMean, the mean calcium concentration; and CaWidth, the heterogeneity of
the mineralization given by the full width at half maximum of the curve.
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2.5. Micro-CT Analysis
Whole crania of animals were retrieved and the samples were fixed in phosphate-
buffered formalin (Roti-Histofix 4%; Carl Roth, Karlsruhe, Germany). Micro-CT scans
were performed with a SCANCO µCT 50 (SCANCO Medical AG, Bruttisellen, Switzer-
land) at 90 kV/200 µA with an isotropic resolution of 20.1 µm and an integration time of
500 ms. Three-dimensional isosurfaces of the collected data were processed using Amira
6.2 (Thermo Fisher Scientific, Waltham, MA, USA). The images were rotated using Fiji [29]
such that the drill direction was oriented along the Z-axis with the defect in the approxi-
mate center of the image. The regions of interest (ROIs) were defined manually, comprising
the areas within and above defect area (defect and above), and segmented automatically
by setting the threshold of 450 mgHA/cm3 to distinguish the mineralized tissue from the
background. The newly formed bone connected to the circumferential bone and the bone
coverage were measured. Calibration and blinding of the examiner were not necessary as
the software performed the analysis automatically using the specifically developed Fiji rule
set which was identical for all samples. The rule set is made available on request.
3. Results
3.1. Histologic Results
The histological analysis identified a heterogeneous pattern of bone formation within
the implanted VSCM (Figures 1–4) in eight specimens (A); one specimen had no bone
formation penetrating into the VSCM (Figure 5). Highly magnified views demonstrated
two types of mineralized tissue formation: (i) the expected new woven bone with the
characteristic osteoblast seams and (ii) clusters of a highly scattered mineralized extra-
cellular matrix resembling hypertrophic chondrocytes during development [30,31] and
endochondral fracture healing [32]. The differentially stained woven bone appears (B) with
pink VSCM fibers entombed or (C) without VSCM. (D) Unexpected large mineralized areas
resembling hypertrophic cartilage can be distinguished from the woven bone by means
of morphology. (E) Areas exclusively occupied by VSCM fibers that appear bluish are
also visible.




Figure 1. Sagittal section of the augmented calvaria going through the defect. (A) The overview shows the formation of 
mineralized tissue inside the VSCM that bridges the defect. The mineralized tissue is heterogeneous in appearance. (B) 
The picture shows the characteristic osteoblasts seams with the unmineralized osteoid. Part of the new bone entombs the 
VSCM fibers that appear pink. (C) The new woven bone also appears without any visible VSCM fibers. (D) We further 
observed a mineralized extracellular matrix that resembles a hypertrophic cartilage-like tissue and (E) areas of VSCM 
fibers appearing as blue connected islands with a void space filed by loosely distributed cells. Scale bars: 2 mm (A) and 
200 μm (B–E have the same magnification). 
 
Figure 2. Mineralized extracellular matrix that looks like a hypertrophic cartilage-like tissue. What becomes obvious is 
that the scattered mineralized tissue appears at a certain distance to the blood vessels (A). The blood vessels (black arrows) 
Figure 1. Sagittal section of the augmented calvaria going through the defect. (A) The overview shows the formation of
mineralized tissue inside the VSCM that bridges the defect. The mineralized tissue is heterogeneous in appearance. (B) The
picture shows the char cteristic osteoblasts seams with the unmineralized osteoid. Part of the new bone entombs the VSCM
fibers that appear pink. (C) The new woven bone lso appears without any visible VSCM fibers. (D) We further observed a
mineralized extracellular matrix that resembles a hypertrophic cartilage-like tissue and (E) areas of VSCM fibers appearing
as blue connected islands with a void space filed by loosely distributed cells. Scale bars: 2 mm (A) and 200 µm (B–E have
the same magnification).
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Figure 2. Mineralized extracellular matrix that looks like a hypertrophic cartilage-like tissue. What becomes obvious is
that the scattered mineralized tissue appears at a certain distance to the blood vessels (A). The blood vessels (black arrows)
have sprouted into the VSCM stained in light pink and are characterized by the erythrocytes that appear in light blue stain
(B). Impressively is the morphology of the mineralizing cells that occasionally form staples, the hallmarks of hypertrophic
chondrocytes in the growth plate (C) but are also loosely distributed in their mineralized matrix (D). The strong uptake of
the dye produces a dark purple stain that indicated higher mineralization of the extracellular matrix compared to the pink
staining of the classical newly formed bone that is produced by the osteoblasts.
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Figure 4. New bone in the defect area. Typical morphology of the newly formed bone with the different shades of dark 
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rated by the osteoid layer from the mineralization zone (B). The osteocytes are embedded in the newly formed osteoid 
layer. The morphological appearance of the newly formed bone is in sharp contrast to the areas considered as mineralized 
chondrogenic cells. 
Figure 3. Mineralized VSCM. We also observed areas i collagen bundles of VSCM w re embed ed in the
dark purple n wly formed mineralized matrix (A), ag in showing the morphol gical features of hypert ophic hondrocytes
with the large lacunae and independent of an osteoid seam that indicates the functional activity of osteoblasts. (B) These
mineralized islands can be next to the outer surface of the VSCM indicated by the paralleled and elongated fibroblastic cells
that are independent and separated from the main front of mineralized tissue formation.
Biomedicines 2021, 9, 732 6 of 13
Biomedicines 2021, 9, x FOR PEER REVIEW 6 of 14 
 
 
have sprouted into the VSCM stained in light pink and are characterized by the erythrocytes that appear in light blue stain 
(B). Impressively is the morphology of the mineralizing cells that occasionally form staples, the hallmarks of hypertrophic 
chondrocytes in the growth plate (C) but are also loosely distributed in their mineralized matrix (D). The strong uptake of 
the dye produces a dark purple stain that indicated higher mineralization of the extracellular matrix compared to the pink 
staining of the classical newly formed bone that is produced by the osteoblasts. 
 
Figure 3. Mineralized VSCM. We also observed areas where the pink collagen bundles of VSCM were embedded in the 
dark purple newly formed mineralized matrix (A), again showing the morphological features of hypertrophic chondro-
cytes with the large lacunae and independent of an osteoid seam that indicates the functional activity of osteoblasts. (B) 
These mineralized islands can be next to the outer surface of the VSCM indicated by the paralleled and elongated fibro-
blastic cells that are independent and separated from the main front of mineralized tissue formation. 
 
Figure 4. New bone in the defect area. Typical morphology of the newly formed bone with the different shades of dark 
pink staining of a bone that forms within the VSCM (A). The ultimate hallmarks of bone are the osteoblastic seams sepa-
rated by the osteoid layer from the mineralization zone (B). The osteocytes are embedded in the newly formed osteoid 
layer. The morphological appearance of the newly formed bone is in sharp contrast to the areas considered as mineralized 
chondrogenic cells. 
Figure 4. New bone in the d fect are . Typical morphology of the newly formed bone with the differ nt shades of dark pink
staining of a bone that forms within the VSCM (A). The ultimate h llm rks of b ne ar the osteoblastic seams separated
by the osteoid layer from the mineralization zone (B). The osteocytes are embedded in the newly formed osteoid layer.
The morphological appearance of the newly formed bone is in sharp contrast to the areas considered as mineralized
chondrogenic cells.




Figure 5. Insights into the VSCM show no mineralization. The specimen that shows no bone formation is depicted in the 
overview (A). The presence of inflammatory infiltrate surrounding the VSCM fibers is visible (B). A higher magnification 
view reveals occasionally multinucleated cells and light purple staining that indicated the presence of newly formed ex-
tracellular matrix produced by spindle-shaped fibroblastic cells (C). 
3.2. Histomorphometric Results 
This analysis was based on the manual segmentation of tissue with a characteristic 
morphology as indicated by Figure 6 showing the false-color staining in the various ROIs. 
The histomorphometric analysis identified newly formed bone without embedded VSCM 
to be in median 0.67 mm2 (0.011 min; 2.4 max) while the new bone with embedded VSCM 
was only 0.06 mm2 (0.0 min; 1.2 max). The mineralized extracellular matrix resembling 
hypertrophic cartilage was 0.66 mm2 (0.0 min; 4.2 max). Most of the area was occupied by 
the remaining VSCM with no mineralized tissue (11.4 mm2, 6.5 min; 14.8 max).  
Figure 5. Insights into t e s o ineralization. The specimen that shows n bone formation is depicted in the
overview (A). The presence of inflammatory infiltrate surrounding the VSCM fibers is visible (B). A higher magnification
view reveals occasionally multinucleated cells and light purple staining that indicated the presence of newly formed
extracellular matrix produced by spindle-shaped fibroblastic cells (C).
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3.2. Histomorphometric Results
This analysis was based on the manual segmentation of tissue with a characteristic
morphology as indicated by Figure 6 showing the false-color staining in the various ROIs.
The histomorphometric analysis identified newly formed bone without embedded VSCM
to be in median 0.67 mm2 (0.011 min; 2.4 max) while the new bone with embedded VSCM
was only 0.06 mm2 (0.0 min; 1.2 max). The mineralized extracellular matrix resembling
hypertrophic cartilage was 0.66 mm2 (0.0 min; 4.2 max). Most of the area was occupied by
the remaining VSCM with no mineralized tissue (11.4 mm2, 6.5 min; 14.8 max).




Figure 6. Histomorphometric analysis—strategy of segmentation and descriptive statistics. The segmentation was based 
on the characteristic features of tissues by high-resolution microscopy. Manual segmentation depicts the new bone alone 
without VSCM (red), the new bone entombing the VSCM (cyan), the extracellular matrix resembling mineralized cartilage 
(mineralized ECM; green), the VSCM alone (yellow), and the remaining soft tissue (white). The bars show the median and 
95% confidence interval. 
3.3. Quantitative Backscattered Electron Imaging (qBEI) 
For further characterization, backscattered electron microscopy was performed. As 
expected, the newly formed woven bone (blue and red ROI) is lower and more heteroge-
neously mineralized than the pre-existing cortical bone of defect margins (yellow ROI) 
(Figure 7 Table 1). This is shown by the low CaPeak and CaMean and the large CaWidth for 
woven bone compared to the pre-existing cortical bone of the calvaria. Moreover, there is 
no significant difference in mineralization between newly formed bone connected to the 
pre-existing cortical bone (blue ROI) and inside the defect (red ROI). In contrast, the chon-
drogenic mineralized extracellular matrix has a remarkably distinct mineralization pat-
tern and different morphology compared to the other tissue types (cyan ROI). The miner-
alization is heterogeneously combining a large portion of lowly mineralized bone, but also 
regions that are higher mineralized than the other tissues (Table 1). 
  
Figure 6. Histomorphometric analysis—strategy of segmentation and descriptive statistics. The segmentation was based
on the characteristic features of tissues by high-resolution icroscopy. Manual segmentation depicts the new bone alone
without VSCM (red), the ne t S (cyan), the extracellular matrix resembling mineralized cartilage
(mineralized ECM; green), the l ( ll ), the re aining soft ti sue (white). The bar show the median and
95% confidence interval.
3.3. Quantitative Backscattered Electron Imaging (qBEI)
For further characterization, backscattered electron microscopy was performed. As
expected, the newly formed woven bone (blue and red ROI) is lower and more hetero-
geneously mineralized than the pre-existing cortical bone of defect margins (yellow ROI)
(Figure 7 Table 1). This is shown by the low CaPeak and CaMean and the large CaWidth for
woven bone compared to the pre-existing cortical bone of the calvaria. Moreover, there
is no significant difference in mineralization between newly formed bone connected to
the pre-existing cortical bone (blue ROI) and inside the defect (red ROI). In contrast, the
chondrogenic mineralized extracellular matrix has a remarkably distinct mineralization
pattern and different morphology compared to the other tissue types (cyan ROI). The
mineralization is heterogeneously combining a large portion of lowly mineralized bone,
but also regions that are higher mineralized than the other tissues (Table 1).
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(∆ wt % Ca)
Cortical bone 24.9 25.5 3.8
New bone periost 22.2 24.4 5.6
New bone defect 22.1 24.4 5.2
Mineralized ECM 17.8 25.1 9.2
The cortical bone shows high and homogenous mineralization, the new bone is less
mineralized than the cortical bone. The mineralized extracellular matrix shows a rather
high mineralization peak but a wide distribution range and a lower mean calcium content
than cortical and new woven bone.
3.4. Microtomographic Findings
In line with the histomorphometric data, hyperdense mineralized tissue was observed
in eight out of nine samples (Figure 8). The overall bone volume in the defect was in
median 1.6 mm3 (min 0.0; max 13.3), the mean trabecular thickness was 0.12 mm in median
(min 0.0; max 0.2). One defect was almost fully covered with new bone tissues but there
was a wide range in the coverage of the defect with a median of 44.4% (min 0; max 99%).
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margins, we measured the bone volume in mm3, the mean trabecular thickness in mm, and the defect
coverage in %. Please note the large variation of the newly formed mineralized tissue within the nine
specimens. The bars show the median and 95% confidence interval.
4. Discussion
VSCMs serve as scaffolds for soft tissue augmentation around teeth or dental im-
plants [10–12,33]. Apart from serving as a space-maintaining scaffold to augment the
soft tissue, VSCM allows for bone formation originating from the underlying ridge de-
fect [15] and supports periodontal regeneration in a canine model [16]. However, studies
to explicitly evaluate the osteoconductive properties of a VSCM in a preclinical setting
are still missing. Therefore, the present pilot study combines different analytical methods
to determine the osteogenic consolidation of a VSCM in rat calvarial defects. We found
different types of mineralized tissues within the VSCM consisting of woven bone and
a heterogeneously mineralized extracellular matrix resembling hypertrophic cartilage.
VSCM fibers entombed within the new bone were only occasionally observed. The os-
teogenic consolidation of a VSCM, however, was not predictable as indicated by the large
variety of bone formation within each specimen and between the individual specimens.
Nevertheless, the present study confirms existing evidence for the possibility of new bone
formation within the VSCM, thus confirming and extending the first reports showing little
bone formation inside the VSCM in a dog model [15,16]. VSCM was also reported to be
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encapsulated by soft tissue without any evidence of mineralization [15,34]. Consistent with
the previous observations, VSCM is not an ideal material to support bone formation and
might be developed towards a biomaterial supporting chondrogenesis.
Further support for this suggestion comes from our observations that VSCM favors the
formation of a mineralized extracellular matrix, that resembles the hypertrophic cartilage-
like tissue of growth plates and ossification centers during development [31] and the
fracture callus [32]. We found aggregated small mineralization nodules surrounding the
cells that featured completely separated but randomly dispersed spheroidal-shaped cells
with a halo. This mineralized extracellular matrix was distinguished from the typical woven
bone formation i.e., apart from the morphology, by the differential staining intensity and
the mineralization distribution. This endochondral healing pattern might be caused by the
sponge-like characteristic of VSCM that is mechanically unstable and slowly vascularized,
both conditions favoring the differentiation of mesenchymal cells into chondrocytes [35].
Even though VSCM failed to release detectable amounts of TGF-β activity into an aque-
ous extraction [36], the endogenous TGF-β may support the chondrogenic differentiation
of the invading mesenchymal cells [36,37]. The role of TGF-β to support chondrogenic dif-
ferentiation remains at the level of a hypothesis. Nevertheless, it is the collagen membranes
that are used in cartilage repair serving as a matrix for the mesenchymal cells originat-
ing from the bone marrow termed “autologous matrix-induced chondrogenesis” [38] or
directly seeded onto the membranes [39]. Thus, it might be possible that VSCM can be
modified in a way to be used for cartilage repair where the transplanted cells usually
undergo fibroblastic differentiation [40,41].
If we relate the findings to those of others, cartilage-like tissue formed in the pores of
copolymer scaffolds not containing TGF-β when transplanted into rat calvaria defects [42].
This is maybe not surprising as calvaria-derived cells are rich in mesenchymal progenitors
with the capacity to differentiate into the chondrogenic lineage under the appropriate
conditions [43]. There is also solid experimental evidence that by increasing the stiffness of
gelatin scaffolds chondrogenesis and thus endochondral ossification is promoted [17,18]. It
seems that some scaffolds and matrices favor this differentiation process, an observation
that leads to new research questions. Our findings and those of others may also inspire the
emerging field of bioprinting allowing us to adapt the properties of collagen to be applied
in various clinical indications including bone but also cartilage regeneration [44].
We acknowledge several limitations of our study. There is strong but indirect evidence
for the presence of endochondral bone formation, similar to the formation of cartilage upon
sinus augmentation [45]. It is the characteristic morphology, in combination with the typical
strong staining of cartilage by the Levai-Laczko [46], together with the shift in the mineral
distribution that points towards the formation of a hypertrophic mineralized cartilage
inside the VSCM. Moreover, considering that also endochondral bone formation during de-
velopment and fracture healing is a continuous process, we observed a gradient where the
mineralized hypertrophic chondrocytes are adjacent to the new bone, further supporting
the impression of an endochondral bone formation. To further strengthen this hypothesis
expression of cartilage markers such as collagen type X and matrix metalloproteinase 13
could be measured [47].
One might also consider a limitation that we have only included one specimen for the
qBEI analysis; that specimen, however, showed the characteristic heterogeneous appear-
ance of the mineralized extracellular matrix that closely resembles hypertrophic cartilage.
The qBEI was not a primary endpoint but only to better understand the mineralization
pattern of this what we think is endochondral bone formation. Considering this limitation
though, the mineral distribution of the pristine and the new woven bone is different from
the endochondral bone formation. Another limitation is that no negative controls have
been performed. Yet, we have positive controls as this research is part of a larger series
of experiments testing the osteoconductive properties of collagen membranes [25,26]. We
have observed an almost complete defect coverage when using a native collagen mem-
brane (Bio-Gide, Geistlich, Wolhusen, Switzerland) as a positive control in rat calvaria
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defects [25,26]. This control is valid for the surgical technique and also the osteogenic
capacity of the calvaria defects. It is thus legitimate to conclude that the VSCM behaves
differently when compared to the native collagen membrane used for guided bone aug-
mentation. Considering that the studies have a different research question, the data were
reported elsewhere [25,26]. Another appropriate control would be a native non-cross-
linked VSCM to understand how the stiffness of the biomaterial affects its chondrogenic
properties.
From a clinical perspective, it would be desirable to modify the VSCM to preserve the
volume stable properties but having also the osteoconductive properties of a porcine colla-
gen membrane [20,21]. Thus, the results of the present study provide new and unexpected
insights into the osteogenic properties of a VSCM and also raise new research questions
that inspire the further development of osteoconductive scaffolds and their clinical appli-
cation. At least in the rat calvaria defect model, VSCM shows a highly variably outcome
in terms of mineralization also indicating a limited capacity to support intramembranous
bone formation but at least allows the formation of bone via the endochondral route. This
observation should not be clinically overinterpreted but may serve as a primer to increase
our understanding of how material properties affect the fate of mesenchymal cells towards
the osteogenic or the chondrogenic lineage.
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